Therapeutic Cannabinoid Formulation Development and Delivery Systems
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Biopharmaceutics".
Deadline for manuscript submissions: closed (20 September 2023) | Viewed by 20249
Special Issue Editor
Interests: patient-centered drug development; fattigation platform; cannabinoid formulation development; solubilization; controlled release; improved bioavailability
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Therapeutic cannabinoids have been exclusively investigated for specific diseases such as chronic pain, cancer, epilepsy, or demystifying novel mechanisms of action related to the human endocannabinoid system. However, strict regulation and biased opinions against cannabis-derived compounds have hampered the research and development of medical cannabis.
Healthcare providers and pharmaceutical scientists are recently beginning to pay great attention to medical cannabis and its potential. The emerging advances in medical cannabis have led to the establishment of a department in the United States Food and Drug Administration (US FDA). Highly standardized medical cannabis is managed by addressing issues related to the extraction and formulation development process.
This Special Issue covers advanced cannabinoid delivery systems and the continual process development for the extraction and formulation of cannabinoids. Based on the therapeutic effects of cannabinoids, the future perspectives of medical cannabis could be provided considering the applicability to other indications.
Dr. Chulhun Park
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- therapeutic cannabinoid
- phytocannabinoids
- cannabidiol
- Δ9-tetrahydrocannabinol
- cannabinoid delivery systems
- lipid-based drug delivery
- bioavailability
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.